ľ�ϸ���Ӱ��

Sabine Fuchs, who has been Professor of Metabolic Diseases and Innovative Therapies for a year, gave her inaugural lecture on 11 July. The lecture, entitled “To the core”, is a plea to invest now in innovation and research to cure serious metabolic diseases and to implement these treatments in a responsible manner so that they become accessible to as many patients as possible.

Sabine begins her argument by noting that, thanks to improved diagnostics, more and more metabolic diseases are being identified. But treatments are lagging behind. And that is serious, because metabolic diseases are the most deadly among children. New treatments must be developed quickly, because children can suffer damage every day. That damage is often preventable, but rarely reversible. Sabine: “That’s why we need to treat early, before irreparable damage occurs. It takes too long to develop a treatment for each of these rare diseases. That’s why I think we need to develop a more general strategy that we can then personalise for all those different metabolic patients who cannot yet be treated adequately.”

Curious what else was in the lecture?